"The diabetic is a critically important patient for pharmacies to serve. Yet, with increased Medicare audits, stringent compliance requirements and reduced reimbursements, is servicing these patients really worth it?" writes Kevin Dore, a director at Emdeon, in his latest blog.
Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.
Low-dose aspirin lowers the occurrence of new venous blood clots — and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study published in Monday's issue of Circulation.